Statistics
Publications
7
Citations
385
H-Index
7
Active since
1999
Kang Feng is an author at Max Planck Institute of Biochemistry specializing in life sciences, structural biology, and biomedical engineering.
Publications per year
1999–2015
7
7
Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma
Xiufeng Jiang, Kang Feng, Ye Zhang et al. · Oncotarget · 2015 · 30 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 7